InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（13 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
13
T+90 胜率
50%
T+90 平均收益
+3.7%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Koenig Sheldon L., 董事长兼首席执行官. Officer active across 1 company, notably Esperion Therapeutics, Inc.. In total, 23 filings have been recorded. Breakdown: 2 buys · 13 sells. Total volume traded: €535k. History available since 17 May 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Koenig Sheldon L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
2,121,094 股Common StockSEC:0001628280-26-047999:0
53,588 股Common StockSEC:0001628280-26-044266:0
25,578 股@ US$2.71919.1% 占其流量Common StockSEC:0001628280-26-019411:0
723,760 股0Common StockSEC:0001628280-26-018192:0
48,244 股@ US$3.67328.2% 占其流量Common StockSEC:0001628280-25-057944:0
28,427 股@ US$2.78817.4% 占其流量Common StockSEC:0001766524-25-000004:0
30,474 股@ US$1.10911.5% 占其流量Common StockSEC:0001628280-25-032218:0
13,047 股@ US$1.5047.9% 占其流量Common StockSEC:0001628280-25-013810:0
840,000 股0Common StockSEC:0001628280-25-013199:0
12,447 股@ US$2.46612.8% 占其流量Common StockSEC:0001628280-24-051868:0
14,550 股@ US$1.79610.3% 占其流量Common StockSEC:0001628280-24-040787:0
454,000 股0Common StockSEC:0001628280-24-011485:0
20,000 股@ US$1.259610.1% 占其流量Common StockSEC:0001628280-23-017231:0
标准退出：2023年8月7日 (T+90)
6,999 股@ US$1.7835.2% 占其流量Common StockSEC:0001628280-23-008610:0
105,000 股0Common StockSEC:0001628280-23-007969:0
5,441 股@ US$5.05611.3% 占其流量Common StockSEC:0001628280-23-006991:0
3,394 股@ US$6.93810.3% 占其流量Common StockSEC:0001628280-22-025217:0
8,606 股@ US$5.804121.4% 占其流量Common StockSEC:0001628280-22-021568:0
标准退出：2022年11月3日 (T+90)
4,552 股@ US$4.9910.0027% mcap90.1% 占其流量Common StockSEC:0001628280-22-017642:0
571 股@ US$4.580.0003% mcap9.9% 占其流量Common StockSEC:0001628280-22-006733:0
116,000 股0Common StockSEC:0001628280-22-006405:0
26,700 股0Common StockSEC:0001628280-21-021009:0
20,000 股0Common StockSEC:0001628280-21-010605:0
23 条申报中的 23 条
About Koenig Sheldon L.
Koenig Sheldon L. is President and CEO at Esperion Therapeutics, Inc. (XNAS). He has 23 filings in total, and across the recent sample of 23 filings, the reported cumulative amounts are EUR 71718 in buys and EUR 463276 in sells, with a modal transaction nature of sell between 2021-05-18 and 2026-07-13.
